XML 67 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Restructuring and impairment charges (credits) (Tables)
 9 Months Ended
Sep. 29, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and Other Impairment Charges
The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three and nine months ended September 29, 2019 and September 30, 2018: 
Three Months Ended September 29, 2019   
Termination benefits
Other costs (1)
Total
(Dollars in thousands) 
2019 Footprint realignment plan$584  $38  $622  
2018 Footprint realignment plan315  74  389  
Other restructuring programs (2)
7  250  257  
Restructuring charges$906  $362  $1,268  
Three Months Ended September 30, 2018   
Termination benefits
Other costs (1)
Total
(Dollars in thousands) 
2018 Footprint realignment plan$1,119  $145  $1,264  
Other restructuring programs (4)
468  232  700  
Restructuring charges1,587  377  1,964  
Asset impairment charges—  17,245  17,245  
Restructuring and impairment charges$1,587  $17,622  $19,209  
Nine Months Ended September 29, 2019  
Termination Benefits
Other costs (1)
Total
(Dollars in thousands)
2019 Footprint realignment plan$13,100  $68  $13,168  
2018 Footprint realignment plan(1,523) 782  (741) 
Other restructuring programs (2)
195  815  1,010  
Restructuring charges11,772  1,665  13,437  
Asset impairment charges—  6,911  6,911  
Restructuring and impairment charges$11,772  $8,576  $20,348  
Nine Months Ended September 30, 2018  
Termination Benefits
Other costs (1)
Total
(Dollars in thousands)
2018 Footprint realignment plan$53,463  $275  $53,738  
2016 Footprint realignment plan (3)
2,379  417  2,796  
Other restructuring programs (4)
1,318  663  1,981  
Restructuring charges57,160  1,355  58,515  
Asset impairment charges—  19,110  19,110  
Restructuring and impairment charges$57,160  $20,465  $77,625  
(1) Other restructuring costs include facility closure, contract termination and other exit costs.
(2) Includes a restructuring program initiated in the third quarter 2019 that is designed to reduce costs and improve efficiencies through reorganizations within several businesses and certain corporate functions, the Vascular Solutions integration program (initiated in 2017) and the 2016 and 2014 Footprint realignment plans.
(3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial.
(4) Includes the Vascular Solutions integration program, the 2014 Footprint realignment plan and the EMEA restructuring program (initiated in 2017).
Summary Of Current Cost Estimates By Major Type Of Cost Table These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s estimates of restructuring and restructuring related charges by major type of expense associated with the 2019 Footprint realignment plan:
Type of expenseTotal estimated amount expected to be incurred
Termination benefits
$19 million to $23 million
Other exit costs (1)
$1 million to $2 million
Restructuring charges
$20 million to $25 million
Restructuring related charges (2)
$36 million to $45 million
Total restructuring and restructuring related charges
$56 million to $70 million
(1)Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized within cost of goods sold.